GLP-1 and GIP receptor agonists in the treatment of Parkinson's disease: translational systematic review and meta-analysis of clinical and preclinical studies

MLA

Vaccari, Carolina. GLP-1 and GIP Receptor Agonists in the Treatment of Parkinson’s Disease: Translational Systematic Review and Meta-Analysis of Clinical and Preclinical Studies. Feb. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3056..934df156218b6aeca7693f2baa95245a&authtype=sso&custid=ns315887.

APA

Vaccari, C. (2022). GLP-1 and GIP receptor agonists in the treatment of Parkinson’s disease: translational systematic review and meta-analysis of clinical and preclinical studies.

Chicago

Vaccari, Carolina. 2022. “GLP-1 and GIP Receptor Agonists in the Treatment of Parkinson’s Disease: Translational Systematic Review and Meta-Analysis of Clinical and Preclinical Studies,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3056..934df156218b6aeca7693f2baa95245a&authtype=sso&custid=ns315887.